Re­al world da­ta and FDA: Drug­mak­ers seek more clar­i­ty on reg­istry guid­ance

As the FDA crafts a new se­ries of guid­ance doc­u­ments on how bio­phar­ma com­pa­nies can use re­al-world da­ta, in­clud­ing pa­tient reg­istries, to help sup­ple­ment their …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER